Application no. and date | 10779339.0 (espacenet) (Federated) (European Patent Register), 20101102 | Patent/reg. no. and date | DK/EP 2498756, 20190904 | Publication date | 20120919 | Priority no. and date | US 259403 P, 20091109 | EP pub. no. and date |
EP 2498756 20120919 | Effective date | | Applicant/owner | Wyeth LLC, 235 East 42nd Street
New York, NY 10017, US | Applicant ref. no. | P70220DK01 | Inventor | ASHRAF, Muhammad, 67 Boulevard
Elmwood Park, New Jersey 07407, US, GHOSH, Krishnendu, Pfizer Inc. 401 N. Middletown Road Building 140-4th Fl.
Pearl River, New York 10965, US, GOOLCHARRAN, Chimanlall, Pfizer Global Research&Development Eastern Point Road
Groton, Connecticut 06340, US, MAHMUD, Mainuddin, 12 Meredith Court
Oak Ridge, New Jersey 07438, US, NAGI, Arwinder Singh, 12366 Nelson Road
Moorpark, California 93021, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4709 (2006.01) , A61K 9/20 (2006.01) , C07D 401/12 (2006.01) | Title | TABLETFORMULERINGER AF NERATINIBMALEAT | Int. application no. | IB2010054964 | Int. publication no. | WO2011055303 | Related patent (certificate) | | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|